Cargando…
Hepatitis B virus–host interactions and novel targets for viral cure
Chronic infection with HBV is a major cause of advanced liver disease and hepatocellular carcinoma. Nucleos(t)ide analogues effectively control HBV replication but viral cure is rare. Hence treatment has often to be administered for an indefinite duration, increasing the risk for selection of drug r...
Autores principales: | Ligat, Gaëtan, Verrier, Eloi R, Nassal, Michael, Baumert, Thomas F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613419/ https://www.ncbi.nlm.nih.gov/pubmed/34029994 http://dx.doi.org/10.1016/j.coviro.2021.04.009 |
Ejemplares similares
-
Targeting Viral cccDNA for Cure of Chronic Hepatitis B
por: Ligat, Gaëtan, et al.
Publicado: (2020) -
Targeting the Host for New Therapeutic Perspectives in Hepatitis D
por: Turon-Lagot, Vincent, et al.
Publicado: (2020) -
Capsid Assembly Modulators as Antiviral Agents against HBV: Molecular Mechanisms and Clinical Perspectives
por: Taverniti, Valerio, et al.
Publicado: (2022) -
Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection
por: Zeisel, Mirjam B., et al.
Publicado: (2015) -
Signaling Induced by Chronic Viral Hepatitis: Dependence and Consequences
por: Boulahtouf, Zakaria, et al.
Publicado: (2022)